Sertraline treatment decreased the serum levels of interleukin-6 and high-sensitivity C-reactive protein in hematopoietic stem cell transplantation patients with depression; a randomized double-blind, placebo-controlled clinical trial
- PMID: 31383995
- DOI: 10.1038/s41409-019-0623-0
Sertraline treatment decreased the serum levels of interleukin-6 and high-sensitivity C-reactive protein in hematopoietic stem cell transplantation patients with depression; a randomized double-blind, placebo-controlled clinical trial
References
-
- Sullivan KM, Mori M, Sanders J, Siadak M, Witherspoon R, Anasetti C, et al. Late complications of allogeneic and autologous marrow transplantation. Bone Marrow Transplant. 1992;10(SUPPL. 1):127–34. - PubMed
-
- Sutcigil L, Oktenli C, Musabak U, Bozkurt A, Cansever A, Uzun O, et al. Pro-and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clin Dev Immunol. 2008;2007:76396. https://doi.org/10.1155/2007/76396
-
- Pizzi C, Mancini S, Angeloni L, Fontana F, Manzoli L, Costa G. Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease. Clin Pharmacol Ther. 2009;86:527. - DOI
-
- Taraz M, Khatami M-R, Dashti-Khavidaki S, Akhonzadeh S, Noorbala A-A, Ghaeli P, et al. Sertraline decreases serum level of interleukin-6 (IL-6) in hemodialysis patients with depression: results of a randomized double-blind, placebo-controlled clinical trial. Int Immunopharmacol. 2013;17:917–23. - DOI
-
- Miller AC, Bershteyn A, Tan W, Hammond PT, Cohen RE, Irvine DJ. Block copolymer micelles as nanocontainers for controlled release of proteins from biocompatible oil phases. Biomacromolecules. 2009;10:732–41. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
